Anthropic claims to be near something along the lines of recursive self-improvement, or RSI, according to the latest revision of its S-1/A filing, published Monday. The new warning in the “Risk ...
In August of 2025, Mercedes-Benz drove an electric EQS sedan 748 miles from Stuttgart, Germany, to Malmö, Sweden. On one charge. And it still had 85 miles of range left. Since the range of a standard ...
For the past few days I’ve been testing an impressive open-weight AI coding model called Flint. It suggests that fully recursive self-improvement, or RSI—an exciting and controversial approach that ...
Factorial Energy Inc. targets high-value battery markets, leveraging superior performance for early aerospace and drone applications before scaling to automotive. FAC is rated ‘Buy’ based on its ...
Solid-state battery specialist Factorial Energy is teaming up with Mitsui Kinzoku, one of the few companies producing sulfide-based solid electrolytes, to scale up the promising new technology.
Factorial Funds, a venture firm launched five years ago by former Cruise engineer Sol Bier, has crossed $1 billion in realized profits, according to a letter the firm is sharing with its investors.
For years now Tim Holme has watched the same drama repeat itself roughly once a week. A headline arrives: some laboratory somewhere has cracked the problem, invented the battery of the future, solved ...
An attorney representing Washington Commanders quarterback Jayden Daniels has informed LSU that it can no longer use his name, image and likeness, according to an Aug. 5 letter sent to Tigers athletic ...
BOSTON, Aug. 11, 2026 (GLOBE NEWSWIRE)-- Factorial Energy Inc. ("Factorial") (Nasdaq: FAC), a global leader in solid-state battery technology, today announced financial and business results for the ...
The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...
Roche Holding AG advanced the first project from its AI drug-discovery partnership with Recursion Pharmaceuticals, marking an early test of whether artificial intelligence can uncover new medicines.